A clinical trial To evaluate hair growth retarding formulation to reduce hair growth against Untreated control on healthy human subjects.

To evaluate hair growth retarding formulation to reduce hair growth against Untreated control on healthy human subjects?.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2009/091/000325

Enrollment

Registered

2010-05-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Ultra Hair Away ?: Spraying twice a day (morning and night) is equivalent to 0.2 gm of the investigational product, which will be applied on specified armpit as per randomization Contro

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female & Male subjects in generally good health. 2. Subjects with normal skin. 3. Subjects age group 18 to 25 years. 4. Subject has not participated in a similar investigation in the past four weeks. 5. Subject has not used a depilatory in the past four weeks. 6. Subject should not use deodorant and body/face powder in the armpit area during study. 7. Subjects willing to give a written informed consent and come for regular follow up. 8. Subject skin Sensitivity test is negative after application of Investigational product on marked area of the left forearm.

Exclusion criteria

Exclusion criteria: ?A Known history or present condition of Allergic response to any cosmetic product. ?Subject having skin disease (e.g. Fungal or other infections at the specified area), which would interfere with the test readings. ?Subjects on medications (e.g. steroids or antihistamines), which would compromise the study. ?Subjects who are pregnant or nursing.

Design outcomes

Primary

Measure	Time frame
To evaluate hair growth retarding formulation to reduce hair growth against Untreated control on healthy human subjects?. Timepoint: on Day 1(Baseline), Day21,Day 28, Day 49 and Day 56 for all the subjects	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr. Aliya Shakeel

Medical Writer

medical@vediclifesciences.com022-42172300

Outcome results